These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29604476)
1. Transcriptional Analysis of the Guinea Pig Mucosal Immune Response to Intravaginal Infection with Herpes Simplex Virus Type 2. Veselenak RL; Milligan GN; Miller AL; Pyles RB; Bourne N Virology; 2018 May; 518():349-357. PubMed ID: 29604476 [TBL] [Abstract][Full Text] [Related]
2. Detection of herpes simplex virus type 2 (HSV-2) -specific cell-mediated immune responses in guinea pigs during latent HSV-2 genital infection. Perry CL; Banasik BN; Gorder SR; Xia J; Auclair S; Bourne N; Milligan GN J Immunol Methods; 2016 Dec; 439():1-7. PubMed ID: 27659010 [TBL] [Abstract][Full Text] [Related]
3. Development of disease and immunity at the genital epithelium following intrarectal inoculation of male guinea pigs with herpes simplex virus type 2. Bourne N; Banasik BN; Perry CL; Miller AL; White M; Pyles RB; Milligan GN Virology; 2019 Jan; 526():180-188. PubMed ID: 30412859 [TBL] [Abstract][Full Text] [Related]
4. Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses. Stanfield BA; Rider PJF; Caskey J; Del Piero F; Kousoulas KG Vaccine; 2018 May; 36(20):2842-2849. PubMed ID: 29655629 [TBL] [Abstract][Full Text] [Related]
5. Use of transcriptional profiling to delineate the initial response of mice to intravaginal herpes simplex virus type 2 infection. Cherpes TL; Harvey SA; Phillips JM; Vicetti Miguel RD; Melan MA; Quispe Calla NE; Hendricks RL Viral Immunol; 2013 Jun; 26(3):172-9. PubMed ID: 23638732 [TBL] [Abstract][Full Text] [Related]
6. Animal models of herpes simplex virus immunity and pathogenesis. Kollias CM; Huneke RB; Wigdahl B; Jennings SR J Neurovirol; 2015 Feb; 21(1):8-23. PubMed ID: 25388226 [TBL] [Abstract][Full Text] [Related]
7. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes. Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955 [TBL] [Abstract][Full Text] [Related]
8. Guinea Pig and Mouse Models for Genital Herpes Infection. Hook LM; Friedman HM; Awasthi S Curr Protoc; 2021 Dec; 1(12):e332. PubMed ID: 34936238 [TBL] [Abstract][Full Text] [Related]
9. Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models. Visalli RJ; Natuk RJ; Kowalski J; Guo M; Blakeney S; Gangolli S; Cooper D Vaccine; 2014 Mar; 32(12):1398-406. PubMed ID: 24462481 [TBL] [Abstract][Full Text] [Related]
10. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens. Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs. Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations. Bernstein DI; Ireland J; Bourne N Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368 [TBL] [Abstract][Full Text] [Related]
13. Increased Frequency of Virus Shedding by Herpes Simplex Virus 2-Infected Guinea Pigs in the Absence of CD4 Bourne N; Perry CL; Banasik BN; Miller AL; White M; Pyles RB; Schäfer H; Milligan GN J Virol; 2019 Feb; 93(4):. PubMed ID: 30463981 [TBL] [Abstract][Full Text] [Related]
14. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. Pyles RB; Higgins D; Chalk C; Zalar A; Eiden J; Brown C; Van Nest G; Stanberry LR J Virol; 2002 Nov; 76(22):11387-96. PubMed ID: 12388699 [TBL] [Abstract][Full Text] [Related]
15. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected. Bourne N; Milligan GN; Stanberry LR; Stegall R; Pyles RB J Infect Dis; 2005 Dec; 192(12):2117-23. PubMed ID: 16288376 [TBL] [Abstract][Full Text] [Related]
16. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530 [TBL] [Abstract][Full Text] [Related]
17. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes. Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327 [TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070 [TBL] [Abstract][Full Text] [Related]
20. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection. Bernstein DI; Tepe ER; Mester JC; Arnold RL; Stanberry LR; Higgins T Vaccine; 1999 Apr; 17(15-16):1964-9. PubMed ID: 10217595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]